Medication

Photo

Hypertension worldwide

Countries vary widely in their capacity to manage hypertension, but globally the majority of diagnosed hypertensives is inadequately controlled. Not treated it can cause cardiovascular disease (CVD), myocardial infarction and stroke. According to the WHO, hypertension is estimated to cause 4.5% of the current global disease burden and is as prevalent in many developing countries as in the…

Photo

SYNCOPE Diagnosis and therapy

The diagnostic work-up of syncope patients often raises the question of how much diagnosis is necessary and what examination methods are really needed. To save time, specialists recommend focusing on determining whether the syncope may be caused by a cardiac problem - a question answered quite easily in many cases. Karl Eberius MD, European Hospital's new correspondent, discussed advice for…

Photo

LIFE Nutrition founded

B. Braun Melsungen AG laid the foundation stone for a new manufacturing plant for production and development in nutrition solutions. The new production site includes a research lab and costs around 190 million Euro. In the future 270 employees will work on innovative denouements for the world market.

Photo

MRSA in US hospitals

Arlington Medical Resources (AMR), a pharmaceutical market research firm, found that the number of patients treated with an antibiotic associated with MRSA-infections within U.S. acute care hospitals has increased 8 percent by the last year. But the average time MRSA-patients had to stay in hospital decreased by 10 percent.

Photo

Know your enemy

Along with MRSA and ESBL bacteria, Clostridium difficile is causing a growing problem. Epidemics of a new C. difficile strain have already occurred in hospitals in North America, England and the Benelux countries.

New drug protects against venous blood clots

In the EU blood clots are responsible for killing 544.000 people each year. Rivaroxaban, a new oral given anticoagulant drug from Bayer Healthcare, is significantly more effective than the current standard of care, according to three recent studies. The number of blood cluts in Europe is about 1.5 million per year, more than thirty percent of the patients affected die.

Photo

TI: Corruption and fraud in the German healthcare system

The German chapter of anti-corruption organisation Transparency International had another close look at the German healthcare system. And it didn't like what it found: In an updated policy paper, member of the board of directors Anke Martiny, deplores that "huge amounts of money belonging to the insured are lost" due to lack of transparency, to corruption and fraud.

On the near horizon

The first FDA-approved prescription medication that reduces blood phenylalanine (Phe) levels in patients with Phenylketonuria (PKU) — a genetic disorder that prevents the normal use of protein foods and can lead to impaired brain development if untreated — could result in more regular screening of blood phenylalanine (Phe) levels in PKU patients.

76 show more articles
Subscribe to Newsletter